# Significo

> Significo builds and licenses healthcare software for insurers, employers, providers and other health businesses. Its work combines custom development, health-data integration and behavioral design with Recco, a personalized recommendation engine, and Balm, a digital intervention platform. Based in Austin with German operations, it sells both enterprise solutions and a consumer Balm subscription.

- **Founded:** 2014
- **Headquarters:** Austin, United States
- **Founders:** Rick McCartney (Co-founder and CEO), Chris Koha (Co-founder and COO)
- **Products:** Recco, Balm, Custom healthcare software, Data integration and analytics, DevOps, hosting and maintenance
- **Notable:** Announced a $12 million Series A in June 2023., Announced a $100 million valuation with its October 2025 Series B., Acquired Vilua Healthcare in 2022, Piobyte in January 2024 and Bunch in July 2024.

## Products & services

- **Recco** — AI and machine-learning health recommendation engine offered as an SDK, API or custom app for integration into existing digital experiences.
- **Balm** — Digital intervention platform with guided programs for anxiety, depression, chronic pain, sleep and type 2 diabetes prevention. The English consumer site lists a seven-day trial followed by $9.99 per month.
- **Custom healthcare software** — Partner-specific mobile and web applications, dashboards and digital health platforms; examples include smoking cessation, occupational health and fitness/nutrition coaching.
- **Data integration and analytics** — Health-data integration, standardized secure exchange, risk modeling and engagement analytics.
- **DevOps, hosting and maintenance** — Infrastructure, continuous integration and deployment, hosting, maintenance and security support for healthcare organizations.
- **Nutrition Database** — Proprietary licensed product named in Significo’s terms of use; public detail is limited.

## Achievements

- Announced a $12 million Series A in June 2023.
- Announced a $100 million valuation with its October 2025 Series B.
- Acquired Vilua Healthcare in 2022, Piobyte in January 2024 and Bunch in July 2024.
- Reports an average 2.5 times longer host-platform activity with personalized Recco recommendations in its own projects.
- Reports threefold customer engagement growth for an insurer’s coaching app.
- Publicly lists ISO 13485 certification; Balm Medical is described in its imprint as a Class I medical device.

## Latest updates

- **2026-08** — Website privacy policy updated August 13, 2026; it names Recco, Nutrition Database and Balm and describes handling of health data.
- **2025-10** — Series B led by JSTAR’s Horizon Fund II announced October 1 with a $100 million valuation and plans for product growth, international expansion and acquisitions.
- **2025-10** — LinkedIn announced a Balm partnership with Urban Sports Club; exact posting day not verified.
- **2025-06** — Rick McCartney published an essay arguing for simpler digital-therapeutic access and payment linked to results.

## Links

- Website: https://www.significo.com/
- LinkedIn: https://www.linkedin.com/company/significo-health/
- Twitter/X: https://twitter.com/significohealth
- GitHub: https://github.com/SignificoHealth
- YouTube: https://www.youtube.com/@significo_
- Instagram: https://www.instagram.com/significohealth/
- Facebook: https://www.facebook.com/significohealth

---

Profile page: https://yespress.io/significo
Published by YesPress — https://yespress.io
Last updated: 2026-10-03